Envista starts new year with intra-oral scanner acquisition

Dental giant Envista will pay $600 million for Carestream Dental’s intra-oral scanner business in a transaction that is expected to close in the second quarter of this year. (Image: astarot/Shutterstock)

Jeremy Booth, Dental Tribune International

Tue. 8. February 2022

save

BREA, Calif., US: Carestream Dental will sell its intra-oral scanner business to Envista Holdings in a deal that will cost the latter US$600 million (€528.5 million). Commenting on the acquisition, Envista CEO Amir Aghdaei emphasised that intra-oral scans are a key step in digital workflows and that Carestream’s technology is world class.

Envista said in a press release in late December 2021 that it had entered into a definitive purchase agreement with Carestream and that the acquisition was expected to close in the second quarter of this year. Envista has previously stated that its long-term strategy for growth is to invest in high-performing segments of the dental business and to offer dentists differentiated solutions that are driven by the digital technologies. The company reiterated this in its announcement of the acquisition.

“With expected annual sales of around US$60 million in 2021, this business is a high-growth, high-margin business that is complementary to both Envista’s equipment and consumables segment and the specialty products and technologies segment,” said Envista, which owns leading dental brands KaVo Kerr, Nobel Biocare and Ormco.

Aghdaei commented: “Intra-oral scans are often the first step in the digital workflow and critical to many high-value dental procedures including implants, prosthetics, and aligners. We are excited to add a suite of world-class intra-oral scanners and software to our portfolio. This acquisition further enables our purpose of partnering with dental professionals to improve patients’ lives by digitising, personalising, and democratising dental care.”

Carestream manufactures dental technologies and is based in Atlanta in the US. It announced the sale agreement in an independent press release, specifying that its scanning technology business included the CS 3600, CS 3700 and CS 3800 intra-oral scanners and related CS ScanFlow software.

The company’s CEO, Lisa Ashby, called Envista a “great new home” for its scanning technology and said that the sale would allow Carestream to focus on other areas of its portfolio, such as artificial intelligence tools and cloud-based applications for dental settings.